Concepedia

Author

R. Adinin

Covance (United States)

Also Known As

R. Adinin, R. B. Adinin, Rosie Adinin

9

Publications

647

Citations

5

H-Index

17

Concepts

All Affiliations

Covance (United States)
RA

About

R. Adinin is an author at Covance (United States) specializing in oncology, radiation oncology, and cancer therapeutics.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

144

2

Pharmacology

4

4

144

3

Health Sciences

3

3

63

4

Biochemistry

1

1

81

5

Cancer Cell Biology

1

1

81

R. Adinin

×

5

Publications

630

Citations

5

H-Index

YearCitations

Phase II Trial of Infusional Fluorouracil, Irinotecan, and Bevacizumab for Metastatic Colorectal Cancer: Efficacy and Circulating Angiogenic Biomarkers Associated With Therapeutic Resistance

Scott Kopetz, Paulo M. Hoff, Jeffrey S. Morris,

Journal of Clinical Oncology

2009

486

A phase I pharmacokinetic (PK) study of MBP-426, a novel liposome encapsulated oxaliplatin

Kamalesh K. Sankhala, Akira Mita, R. Adinin,

Journal of Clinical Oncology

2009

81

Phase I study to determine the safety of oral administration of TAS-102 on a twice daily (BID) schedule for five days a week (wk) followed by two days rest for two wks, every (Q) four wks in patients (pts) with metastatic breast cancer (MBC)

M. C. Green, Lajos Pusztai, R. Theriault,

Journal of Clinical Oncology

2006

31

Preliminary results from a phase II study of infusional 5-FU, leucovorin, and irinotecan (FOLFIRI) plus bevacizumab as first-line treatment for metastatic colorectal cancer (mCRC)

Scott Kopetz, James L. Abbruzzese, Cathy Eng,

Journal of Clinical Oncology

2006

22

Phase II study of infusional 5-fluorouracil, leucovorin, and irinotecan (FOLFIRI) plus bevacizumab as first-line treatment for metastatic colorectal cancer

Scott Kopetz, K. Y. Glover, Cathy Eng,

Journal of Clinical Oncology

2007

10

Page 1